Dynavax Technologies
DVAX
#5495
Rank
โ‚ฌ1.09 B
Marketcap
9,35ย โ‚ฌ
Share price
-0.64%
Change (1 day)
-22.83%
Change (1 year)

Dynavax Technologies (DVAX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.81 Billion

According to Dynavax Technologies 's latest financial reports the company's total assets are โ‚ฌ0.81 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Dynavax Technologies - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.94 B5.08%
2023-12-31โ‚ฌ0.90 B-1.86%
2022-12-31โ‚ฌ0.91 B0.15%
2021-12-31โ‚ฌ0.91 B219.5%
2020-12-31โ‚ฌ0.28 B15.29%
2019-12-31โ‚ฌ0.24 B35.14%
2018-12-31โ‚ฌ0.18 B1.1%
2017-12-31โ‚ฌ0.18 B74.87%
2016-12-31โ‚ฌ0.10 B-47.37%
2015-12-31โ‚ฌ0.19 B74.25%
2014-12-31โ‚ฌ0.11 B-23.26%
2013-12-31โ‚ฌ0.14 B40.24%
2012-12-31โ‚ฌ0.10 B2.31%
2011-12-31โ‚ฌ0.10 B63.03%
2010-12-31โ‚ฌ63.33 M79.8%
2009-12-31โ‚ฌ35.22 M-45.66%
2008-12-31โ‚ฌ64.82 M-21.42%
2007-12-31โ‚ฌ82.49 M5.79%
2006-12-31โ‚ฌ77.97 M15.33%
2005-12-31โ‚ฌ67.61 M24.54%
2004-12-31โ‚ฌ54.29 M116.41%
2003-12-31โ‚ฌ25.08 M-16.69%
2002-12-31โ‚ฌ30.11 M75.92%
2001-12-31โ‚ฌ17.11 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
โ‚ฌ0.20 B-75.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ25.08 B 2,985.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ111.26 B 13,586.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ50.27 B 6,084.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ98.30 B 11,992.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚ฌ70.82 B 8,612.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ179.27 B 21,952.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ34.23 B 4,110.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ77.42 B 9,423.55%๐Ÿ‡บ๐Ÿ‡ธ USA